GMDA Stock Earnings: Gamida Cell Beats EPS, Beats Revenue for Q4 2023
Gamida Cell (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to…
Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gamida Cell (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to…
Gamida Cell Ltd. (GMDA), a company focused on cell therapy, on Wednesday reported a narrower loss for the full year, supported by an increase in financial income of $14.
Gamida Cell Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 1.78 million. Net loss was USD 63 million compared to USD...
The Israeli stem cell company will lay off 25% of its workforce and close its Jerusalem development center.
Gamida Cell shares plummet as the company enters a restructuring agreement with Highbridge Capital Management, aiming to secure long-term financial stability.